AA34142
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
1mg | 97% | in stock | $15.00 | $11.00 | - + | |
5mg | 97% | in stock | $44.00 | $31.00 | - + | |
10mg | 97% | in stock | $54.00 | $38.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AA34142 |
Chemical Name: | N-Alpha-fmoc-o-beta-(2-acetamido-2-deoxy-3,4,6-tri-o-acetyl-alpha-d-galactopyranosyl)-l-serine |
CAS Number: | 120173-57-1 |
Molecular Formula: | C32H36N2O13 |
Molecular Weight: | 656.6338 |
MDL Number: | MFCD00171375 |
SMILES: | CC(=O)OC[C@H]1O[C@H](OC[C@@H](C(=O)O)NC(=O)OCC2c3ccccc3c3c2cccc3)[C@@H]([C@H]([C@H]1OC(=O)C)OC(=O)C)NC(=O)C |
Fmoc-L-Ser(alpha-D-GalNAc(Ac)3)-OH is a specialized building block commonly utilized in chemical synthesis for the selective modification of serine residues. This compound is particularly valuable in peptide chemistry, where it serves as a crucial tool for the controlled installation of N-acetylgalactosamine (GalNAc) moieties onto serine residues within peptide sequences.By utilizing Fmoc-L-Ser(alpha-D-GalNAc(Ac)3)-OH in chemical synthesis, researchers can introduce specific sugar modifications at precise locations along peptide chains. This targeted glycosylation strategy is essential for generating glycopeptides with tailored biological activities or studying glycoprotein structures. The presence of the Fmoc protecting group facilitates selective deprotection and subsequent functionalization steps, enabling efficient incorporation of the GalNAc moiety with high purity and yield.Furthermore, the unique combination of serine and GalNAc functionalities in Fmoc-L-Ser(alpha-D-GalNAc(Ac)3)-OH offers opportunities for the creation of glycopeptide mimetics or glycosylated proteins with potential therapeutic applications. This compound's versatility and compatibility with solid-phase peptide synthesis make it a valuable tool for advancing research in the fields of chemical biology, drug discovery, and bioconjugation.